person · Reporting owner

Roby Anne K

Disclosed activity across 4 companies

Tapewire entity: 48970
SEC CIK: 0001595290

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
LINDE PLCLIN · Entity 2835	Executive Vice President	June 03, 2020	June 04, 2020
ROGERS CORPROG · Entity 4438	Director	May 06, 2026	May 08, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

LINDE PLC

Report date June 03, 2020 · Filed June 04, 2020

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Ordinary SharesSEC Table I · non-derivative	Direct	31,292.522	Ending reported balance After 2020-06-03 transaction · row 5 5 source rows · reconciled sequence Row 1 · 2020-06-03 · Exercise / conversion · Acquired 9,405 · Balance 40,697.522 Row 2 · 2020-06-03 · Tax withholding · Disposed 6,792 · Balance 33,905.522 F1: Shares withheld from option exercise to pay exercise price and taxes. No market sale of shares occurred. Row 3 · 2020-06-03 · Exercise / conversion · Acquired 15,790 · Balance 49,695.522 Row 4 · 2020-06-03 · Tax withholding · Disposed 11,732 · Balance 37,963.522 F1: Shares withheld from option exercise to pay exercise price and taxes. No market sale of shares occurred. Row 5 · 2020-06-03 · Sale · Disposed 6,671 · Balance 31,292.522 F2: The price reported is the weighted average sale price. The sale prices ranged from $211.73 to $212.14. Upon request of the SEC Staff, Linde plc or a security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price.
Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $110.58 · Expires 2023-02-26	Direct	0	Reported balance After 2020-06-03 transaction · row 12 Instrument identity requires review; Table II rows are not merged. 1 source row Row 12 · 2020-06-03 · Exercise / conversion · Disposed 15,790 · Balance 0 F8: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant.
Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $102.22 · Expires 2026-02-23	Direct	40,000	Reported balance After 2020-06-03 transaction · row 15 Instrument identity requires review; Table II rows are not merged. 1 source row Row 15 · 2020-06-03 · Exercise / conversion · Disposed 9,405 · Balance 40,000 F9: This option vests over three years in three consecutive equal annual installments beginning on February 23, 2017.
Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $173.13 · Expires 2030-03-09	Direct	23,545	Reported balance Holding disclosure · report date 2020-06-03 · row 10 Instrument identity requires review; Table II rows are not merged. 1 source row Row 10 · Balance 23,545 F6: This option vests over three years in three consecutive equal annual installments beginning on March 9, 2021.
Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $176.63 · Expires 2029-03-20	Direct	26,230	Reported balance Holding disclosure · report date 2020-06-03 · row 11 Instrument identity requires review; Table II rows are not merged. 1 source row Row 11 · Balance 26,230 F7: This option vests over three years in three consecutive equal annual installments beginning on March 20, 2020.
Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $128.80 · Expires 2024-02-25	Direct	19,900	Reported balance Holding disclosure · report date 2020-06-03 · row 13 Instrument identity requires review; Table II rows are not merged. 1 source row Row 13 · Balance 19,900 F8: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant.
Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $128.38 · Expires 2025-02-24	Direct	26,490	Reported balance Holding disclosure · report date 2020-06-03 · row 14 Instrument identity requires review; Table II rows are not merged. 1 source row Row 14 · Balance 26,490 F8: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant.
Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $118.71 · Expires 2027-02-28	Direct	39,585	Reported balance Holding disclosure · report date 2020-06-03 · row 16 Instrument identity requires review; Table II rows are not merged. 1 source row Row 16 · Balance 39,585 F10: This option vests over three years in three consecutive equal annual installments beginning on February 28, 2018.
Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $154.00 · Expires 2028-02-27	Direct	32,335	Reported balance Holding disclosure · report date 2020-06-03 · row 17 Instrument identity requires review; Table II rows are not merged. 1 source row Row 17 · Balance 32,335 F11: Conversion to Linde plc ordinary shares is on a one-for-one basis.
Ordinary SharesSEC Table I · non-derivative	Indirect401(k)	1,709.075	Reported balance Holding disclosure · report date 2020-06-03 · row 6 Holding and transaction disclosures are not merged. 1 source row Row 6 · Balance 1,709.075
Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	1,935	Reported balance Holding disclosure · report date 2020-06-03 · row 7 Instrument identity requires review; Table II rows are not merged. 1 source row Row 7 · Balance 1,935 F3: Restricted Stock Units that will vest in full and payout on or about March 9, 2023 in Linde plc Ordinary Shares on a one-for-one basis.
Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	2,330	Reported balance Holding disclosure · report date 2020-06-03 · row 8 Instrument identity requires review; Table II rows are not merged. 1 source row Row 8 · Balance 2,330 F4: Restricted Stock Units that will vest in full and payout on or about March 20, 2022 in Linde plc Ordinary Shares on a one-for-one-basis.
Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	3,885	Reported balance Holding disclosure · report date 2020-06-03 · row 9 Instrument identity requires review; Table II rows are not merged. 1 source row Row 9 · Balance 3,885 F5: Restricted Stock units that will vest in full and payout on or about February 23, 2021 in Linde plc Ordinary Shares on a one-for-one basis.
Deferred Stock UnitSEC Table II · derivative / convertible security	Direct	120.569	Reported balance Holding disclosure · report date 2020-06-03 · row 18 Instrument identity requires review; Table II rows are not merged. 1 source row Row 18 · Balance 120.569 F11: Conversion to Linde plc ordinary shares is on a one-for-one basis. F12: Deferred stock units acquired under the Compensation Deferred Plan as amended ("Plan"). The deferred stock units will payout in Linde plc Ordinary Shares on a one-for one basis in accordance with the Plan.

Filing footnotes · ownership attribution and instrument terms

F1: Shares withheld from option exercise to pay exercise price and taxes. No market sale of shares occurred.

F2: The price reported is the weighted average sale price. The sale prices ranged from $211.73 to $212.14. Upon request of the SEC Staff, Linde plc or a security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price.

F3: Restricted Stock Units that will vest in full and payout on or about March 9, 2023 in Linde plc Ordinary Shares on a one-for-one basis.

F4: Restricted Stock Units that will vest in full and payout on or about March 20, 2022 in Linde plc Ordinary Shares on a one-for-one-basis.

F5: Restricted Stock units that will vest in full and payout on or about February 23, 2021 in Linde plc Ordinary Shares on a one-for-one basis.

F6: This option vests over three years in three consecutive equal annual installments beginning on March 9, 2021.

F7: This option vests over three years in three consecutive equal annual installments beginning on March 20, 2020.

F8: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant.

F9: This option vests over three years in three consecutive equal annual installments beginning on February 23, 2017.

F10: This option vests over three years in three consecutive equal annual installments beginning on February 28, 2018.

F11: Conversion to Linde plc ordinary shares is on a one-for-one basis.

F12: Deferred stock units acquired under the Compensation Deferred Plan as amended ("Plan"). The deferred stock units will payout in Linde plc Ordinary Shares on a one-for one basis in accordance with the Plan.

ROGERS CORP

Report date May 06, 2026 · Filed May 08, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Capital (Common) StockSEC Table I · non-derivative	Direct	6,837	Reported balance After 2026-05-06 transaction · row 1 1 source row Row 1 · 2026-05-06 · Grant · Acquired 1,427 · Balance 6,837 F1: Represents shares of Rogers Corporation Capital (Common) Stock receivable pursuant to the May 6, 2026, award of deferred stock units.
Capital (Common) StockSEC Table I · non-derivative	IndirectSpousal Access Trust	615	Reported balance Holding disclosure · report date 2026-05-06 · row 2 Holding and transaction disclosures are not merged. 1 source row Row 2 · Balance 615

Filing footnotes · ownership attribution and instrument terms

F1: Represents shares of Rogers Corporation Capital (Common) Stock receivable pursuant to the May 6, 2026, award of deferred stock units.

Past disclosures · reporting ended (2)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

CMC Materials, Inc.

Report date July 06, 2022 · Filed July 07, 2022

Section 16 reporting ended · disclosed 2022-07-07. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	0	Reported balance After 2022-07-06 transaction · row 1 1 source row Row 1 · 2022-07-06 · Disposition to issuer · Disposed 1,897 · Balance 0 F1: Disposed of in connection with the transactions contemplated by the Agreement and Plan of Merger, dated as of December 14, 2021 (the "Merger Agreement"), by and among the Issuer, Entegris, Inc. ("Entegris") and Yosemite Merger Sub, Inc. ("Merger Sub"), a Delaware corporation and a wholly owned subsidiary of Entegris, pursuant to which the Issuer was merged with and into Merger Sub, with the Issuer surviving as a wholly owned subsidiary of Entegris (the "Merger"). Pursuant to the Merger Agreement, at the effective time of the Merger, each share of Issuer common stock was cancelled and converted into (i) $133.00 in cash and (ii) 0.4506 of a share of Entegris common stock, with cash in lieu of any fractional shares of Entegris common stock (together, the "Merger Consideration"). The Merger closed on July 6, 2022. On July 5, 2022, the closing price of the Issuer was $173.69, and the closing price of Entegris was $90.75. As a result of the Merger, the reporting person no longer beneficially owns, directly or indirectly, any shares of Issuer common stock.
Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $154.00 · Expires 2031-06-01	Direct	0	Reported balance After 2022-07-06 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2022-07-06 · Disposition to issuer · Disposed 1,107 · Balance 0 F2: Pursuant to the Merger Agreement, at the effective time of the Merger, each outstanding option to purchase shares of Issuer common stock (an "Issuer Option") vested in full and was assumed and converted into an option to purchase shares of Entegris common stock (an "Entegris Option"), as adjusted based on the Equity Award Exchange Ratio (as defined in the Merger Agreement). F3: This Issuer Option, which originally provided for vesting in four equal annual installments beginning on 6/1/2022, vested in full and was assumed and converted into an Entegris Option to purchase 2,015 shares of Entegris common stock an exercise price of $84.59 per share.

Filing footnotes · ownership attribution and instrument terms

F1: Disposed of in connection with the transactions contemplated by the Agreement and Plan of Merger, dated as of December 14, 2021 (the "Merger Agreement"), by and among the Issuer, Entegris, Inc. ("Entegris") and Yosemite Merger Sub, Inc. ("Merger Sub"), a Delaware corporation and a wholly owned subsidiary of Entegris, pursuant to which the Issuer was merged with and into Merger Sub, with the Issuer surviving as a wholly owned subsidiary of Entegris (the "Merger"). Pursuant to the Merger Agreement, at the effective time of the Merger, each share of Issuer common stock was cancelled and converted into (i) $133.00 in cash and (ii) 0.4506 of a share of Entegris common stock, with cash in lieu of any fractional shares of Entegris common stock (together, the "Merger Consideration"). The Merger closed on July 6, 2022. On July 5, 2022, the closing price of the Issuer was $173.69, and the closing price of Entegris was $90.75. As a result of the Merger, the reporting person no longer beneficially owns, directly or indirectly, any shares of Issuer common stock.

F2: Pursuant to the Merger Agreement, at the effective time of the Merger, each outstanding option to purchase shares of Issuer common stock (an "Issuer Option") vested in full and was assumed and converted into an option to purchase shares of Entegris common stock (an "Entegris Option"), as adjusted based on the Equity Award Exchange Ratio (as defined in the Merger Agreement).

F3: This Issuer Option, which originally provided for vesting in four equal annual installments beginning on 6/1/2022, vested in full and was assumed and converted into an Entegris Option to purchase 2,015 shares of Entegris common stock an exercise price of $84.59 per share.

PRAXAIR INC

Report date October 31, 2018 · Filed November 01, 2018

Section 16 reporting ended · disclosed 2018-11-01. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosure context
Common StockSEC Table I · non-derivative	Indirect401(k)	Reported balance After 2018-10-31 transaction · row 1 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 1 · 2018-10-31 · Disposition to issuer · Disposed 1,328.5434 · Balance 0 F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc.
Common StockSEC Table I · non-derivative	Direct	Reported balance After 2018-10-31 transaction · row 2 1 source row Row 2 · 2018-10-31 · Disposition to issuer · Disposed 26,747.951 · Balance 0 F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc.
Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	Reported balance After 2018-10-31 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2018-10-31 · Disposition to issuer · Disposed 3,885 · Balance 0 F2: Restricted Stock Units that were previously awarded by Praxair, Inc. will vest 100% on February 27, 2021. In connection with the BCA, the RSUs have been converted into RSUs of Linde plc Ordinary Shares on a one-for-one basis. F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc.
Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	Reported balance After 2018-10-31 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2018-10-31 · Disposition to issuer · Disposed 3,510 · Balance 0 F3: Restricted Stock Units previously awarded by Praxair, Inc. on February 23, 2016 that will vest and payout on February 23, 2019. In connection with the BCA, the RSUs were converted to RSUs of Linde plc Ordinary Shares on a one-for-one basis. F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc.
Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	Reported balance After 2018-10-31 transaction · row 5 Instrument identity requires review; Table II rows are not merged. 1 source row Row 5 · 2018-10-31 · Disposition to issuer · Disposed 4,328 · Balance 0 F4: Restricted Stock Units previously awarded by Praxair, Inc. on February 28, 2017 that will vest and payout on February 28, 2020. In connection with the BCA, the RSUs were converted to RSUs of Linde plc Ordinary Shares on a one-for-one basis. F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc.
Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	Reported balance After 2018-10-31 transaction · row 6 Instrument identity requires review; Table II rows are not merged. 1 source row Row 6 · 2018-10-31 · Disposition to issuer · Disposed 3,588 · Balance 0 F3: Restricted Stock Units previously awarded by Praxair, Inc. on February 23, 2016 that will vest and payout on February 23, 2019. In connection with the BCA, the RSUs were converted to RSUs of Linde plc Ordinary Shares on a one-for-one basis. F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc.
Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	Reported balance After 2018-10-31 transaction · row 7 Instrument identity requires review; Table II rows are not merged. 1 source row Row 7 · 2018-10-31 · Disposition to issuer · Disposed 2,960 · Balance 0 F4: Restricted Stock Units previously awarded by Praxair, Inc. on February 28, 2017 that will vest and payout on February 28, 2020. In connection with the BCA, the RSUs were converted to RSUs of Linde plc Ordinary Shares on a one-for-one basis. F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc.
Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $97.84 · Expires 2021-02-22	Direct	Reported balance After 2018-10-31 transaction · row 8 Instrument identity requires review; Table II rows are not merged. 1 source row Row 8 · 2018-10-31 · Disposition to issuer · Disposed 13,195 · Balance 0 F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. F5: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant. and was fully vested and exercisable. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option.
Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $109.68 · Expires 2022-02-28	Direct	Reported balance After 2018-10-31 transaction · row 9 Instrument identity requires review; Table II rows are not merged. 1 source row Row 9 · 2018-10-31 · Disposition to issuer · Disposed 18,430 · Balance 0 F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. F5: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant. and was fully vested and exercisable. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option.
Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $110.58 · Expires 2023-02-26	Direct	Reported balance After 2018-10-31 transaction · row 10 Instrument identity requires review; Table II rows are not merged. 1 source row Row 10 · 2018-10-31 · Disposition to issuer · Disposed 15,790 · Balance 0 F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. F5: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant. and was fully vested and exercisable. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option.
Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $128.80 · Expires 2024-02-25	Direct	Reported balance After 2018-10-31 transaction · row 11 Instrument identity requires review; Table II rows are not merged. 1 source row Row 11 · 2018-10-31 · Disposition to issuer · Disposed 19,900 · Balance 0 F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. F5: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant. and was fully vested and exercisable. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option.
Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $128.38 · Expires 2025-02-24	Direct	Reported balance After 2018-10-31 transaction · row 12 Instrument identity requires review; Table II rows are not merged. 1 source row Row 12 · 2018-10-31 · Disposition to issuer · Disposed 26,490 · Balance 0 F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. F5: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant. and was fully vested and exercisable. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option.
Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $102.22 · Expires 2026-02-23	Direct	Reported balance After 2018-10-31 transaction · row 13 Instrument identity requires review; Table II rows are not merged. 1 source row Row 13 · 2018-10-31 · Disposition to issuer · Disposed 49,405 · Balance 0 F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. F6: This options vests over three years in three consecutive equal annual installments beginning on February 23, 2017. In accordance with the Buiness Combination Agreement , each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option.
Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $118.71 · Expires 2027-02-28	Direct	Reported balance After 2018-10-31 transaction · row 14 Instrument identity requires review; Table II rows are not merged. 1 source row Row 14 · 2018-10-31 · Disposition to issuer · Disposed 39,585 · Balance 0 F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. F7: This option vests over three years in three consecutive equal annual installments beginning on February 28, 2018. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option.
Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $154.00 · Expires 2028-02-27	Direct	Reported balance After 2018-10-31 transaction · row 15 Instrument identity requires review; Table II rows are not merged. 1 source row Row 15 · 2018-10-31 · Disposition to issuer · Disposed 32,335 · Balance 0 F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. F8: This option vests over three years in three consecutive equal annual installments beginning on February 27, 2019. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option.

Filing footnotes · ownership attribution and instrument terms

F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc.

F2: Restricted Stock Units that were previously awarded by Praxair, Inc. will vest 100% on February 27, 2021. In connection with the BCA, the RSUs have been converted into RSUs of Linde plc Ordinary Shares on a one-for-one basis.

F3: Restricted Stock Units previously awarded by Praxair, Inc. on February 23, 2016 that will vest and payout on February 23, 2019. In connection with the BCA, the RSUs were converted to RSUs of Linde plc Ordinary Shares on a one-for-one basis.

F4: Restricted Stock Units previously awarded by Praxair, Inc. on February 28, 2017 that will vest and payout on February 28, 2020. In connection with the BCA, the RSUs were converted to RSUs of Linde plc Ordinary Shares on a one-for-one basis.

F5: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant. and was fully vested and exercisable. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option.

F6: This options vests over three years in three consecutive equal annual installments beginning on February 23, 2017. In accordance with the Buiness Combination Agreement , each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option.

F7: This option vests over three years in three consecutive equal annual installments beginning on February 28, 2018. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option.

F8: This option vests over three years in three consecutive equal annual installments beginning on February 27, 2019. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
May 06, 2026 Filed May 8, 2026 16:35 UTC	ROGERS CORP ROG · Entity 4438	GrantCapital (Common) Stock	1,427	$0.00	$0.00	Disclosure SEC source: 0001595290-26-000001 · f4_a1eus000008idrzma2-live.xml · nonDerivative · entry 1 Roby Anne K · CIK 0001595290 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,837 F1 · shares: Represents shares of Rogers Corporation Capital (Common) Stock receivable pursuant to the May 6, 2026, award of deferred stock units. Read SEC document
May 05, 2025 Filed May 7, 2025 20:25 UTC	ROGERS CORP ROG · Entity 4438	GrantCapital (Common) Stock	2,760	$0.00	$0.00	Disclosure SEC source: 0001664272-25-000293 · f4_a1eus0000051oj3maa-live.xml · nonDerivative · entry 1 Roby Anne K · CIK 0001595290 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,410 F1 · shares: Represents shares of Rogers Corporation Capital (Common) Stock receivable pursuant to the May 5, 2025, award of deferred stock units. Read SEC document
May 02, 2024 Filed May 6, 2024 18:19 UTC	ROGERS CORP ROG · Entity 4438	GrantCapital (Common) Stock	1,500	$0.00	$0.00	Disclosure SEC source: 0001664272-24-000255 · f4_a1edp0000016phhmam-live.xml · nonDerivative · entry 1 Roby Anne K · CIK 0001595290 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,650 F1 · shares: Represents shares of Rogers Corporation Capital (Common) Stock receivable pursuant to the May 2, 2024, award of deferred stock units. Read SEC document
August 09, 2023 Filed Aug 10, 2023 16:52 UTC	ROGERS CORP ROG · Entity 4438	PurchaseCapital (Common) Stock	315	$148.06	$46,638.84	Disclosure SEC source: 0001664272-23-000405 · f4_a1e2k00000whixtuat-live.xml · nonDerivative · entry 1 Roby Anne K · CIK 0001595290 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Spousal Access Trust Disclosed balance after: 615 Read SEC document
May 04, 2023 Filed May 5, 2023 21:52 UTC	ROGERS CORP ROG · Entity 4438	GrantCapital (Common) Stock	950	$0.00	$0.00	Disclosure SEC source: 0001664272-23-000333 · f4_a1e2k00000rxsshuad-live.xml · nonDerivative · entry 1 Roby Anne K · CIK 0001595290 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,150 F1 · shares: Represents shares of Rogers Corporation Capital (Common) Stock receivable pursuant to the May 4, 2023, award of deferred stock units. Read SEC document
May 01, 2023 Filed May 3, 2023 17:12 UTC	ROGERS CORP ROG · Entity 4438	PurchaseCapital (Common) Stock	300	$162.01	$48,604.20	Disclosure SEC source: 0001664272-23-000313 · f4_a1e2k00000rxslquad-live.xml · nonDerivative · entry 1 Roby Anne K · CIK 0001595290 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Spousal Access Trust Disclosed balance after: 300 Read SEC document
March 09, 2023 Filed Mar 10, 2023 20:38 UTC	ROGERS CORP ROG · Entity 4438	GrantCapital (Common) Stock	200	$0.00	$0.00	Disclosure SEC source: 0001664272-23-000209 · f4_a1e2k00000rxrhiuad-live.xml · nonDerivative · entry 1 Roby Anne K · CIK 0001595290 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200 F1 · shares: Dr. Roby was appointed to the Board of Directors of Issuer on February 26, 2023. This figure represents the number of shares of the Issuer's Capital (Common) Stock receivable pursuant to the deferred stock units granted to Dr. Roby on March 9, 2023. The award is consistent with Issuer's compensatory arrangements for non-management directors, as described in the Form 10-K filed on February 22, 2022, and has been prorated based on the date of Dr. Roby's appointment to the Board. Read SEC document
July 06, 2022 Filed Jul 7, 2022 09:11 UTC	CMC Materials, Inc. CCMP · Entity 125533	Disposition to issuerStock Options (Right to Buy) · Derivative	1,107	$0.00 Strike: $154.00	$0.00	Disclosure SEC source: 0001127602-22-019026 · form4.xml · derivative · entry 2 Roby Anne K · CIK 0001595290 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,107 shares Expires 2031-06-01 F2 · derivative.exercise_date: Pursuant to the Merger Agreement, at the effective time of the Merger, each outstanding option to purchase shares of Issuer common stock (an "Issuer Option") vested in full and was assumed and converted into an option to purchase shares of Entegris common stock (an "Entegris Option"), as adjusted based on the Equity Award Exchange Ratio (as defined in the Merger Agreement). F3 · derivative.exercise_date: This Issuer Option, which originally provided for vesting in four equal annual installments beginning on 6/1/2022, vested in full and was assumed and converted into an Entegris Option to purchase 2,015 shares of Entegris common stock an exercise price of $84.59 per share. Read SEC document
July 06, 2022 Filed Jul 7, 2022 09:11 UTC	CMC Materials, Inc. CCMP · Entity 125533	Disposition to issuerCommon Stock	1,897	Not disclosed	Not disclosed	Disclosure SEC source: 0001127602-22-019026 · form4.xml · nonDerivative · entry 1 Roby Anne K · CIK 0001595290 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: Disposed of in connection with the transactions contemplated by the Agreement and Plan of Merger, dated as of December 14, 2021 (the "Merger Agreement"), by and among the Issuer, Entegris, Inc. ("Entegris") and Yosemite Merger Sub, Inc. ("Merger Sub"), a Delaware corporation and a wholly owned subsidiary of Entegris, pursuant to which the Issuer was merged with and into Merger Sub, with the Issuer surviving as a wholly owned subsidiary of Entegris (the "Merger"). Pursuant to the Merger Agreement, at the effective time of the Merger, each share of Issuer common stock was cancelled and converted into (i) $133.00 in cash and (ii) 0.4506 of a share of Entegris common stock, with cash in lieu of any fractional shares of Entegris common stock (together, the "Merger Consideration"). The Merger closed on July 6, 2022. On July 5, 2022, the closing price of the Issuer was $173.69, and the closing price of Entegris was $90.75. As a result of the Merger, the reporting person no longer beneficially owns, directly or indirectly, any shares of Issuer common stock. Read SEC document
March 09, 2022 Filed Mar 10, 2022 08:09 UTC	CMC Materials, Inc. CCMP · Entity 125533	GrantCommon Stock	973	$0.00	$0.00	Disclosure SEC source: 0001127602-22-008839 · form4.xml · nonDerivative · entry 1 Roby Anne K · CIK 0001595290 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,897 F1 · shares: Directors' Annual (2022) Restricted Stock Unit Award pursuant to 2021 Omnibus Incentive Plan ("2021 OIP"); 100% will vest on 3/9/2023 Read SEC document
June 01, 2021 Filed Jun 2, 2021 16:33 UTC	CMC Materials, Inc. CCMP · Entity 125533	GrantStock Options (Right to Buy) · Derivative	1,107	$154.00 Strike: $154.00	$170,478.00	Disclosure SEC source: 0001127602-21-018708 · form4.xml · derivative · entry 3 Roby Anne K · CIK 0001595290 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,107 Underlying: Common Stock · 1,107 shares Expires 2031-06-01 F3 · shares: Directors' Annual (2021) Non-Qualified Stock Option Grant pursuant to 2021 Omnibus Incentive Plan ("2021 OIP"); 100% will vest on 6/1/2022. Read SEC document
June 01, 2021 Filed Jun 2, 2021 16:33 UTC	CMC Materials, Inc. CCMP · Entity 125533	GrantCommon Stock	394	$0.00	$0.00	Disclosure SEC source: 0001127602-21-018708 · form4.xml · nonDerivative · entry 2 Roby Anne K · CIK 0001595290 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 924 F2 · shares: Directors' Annual (2021) Restricted Stock Unit Award pursuant to 2021 Omnibus Incentive Plan ("2021 OIP"); 100% will vest on 6/1/2022. Read SEC document
June 01, 2021 Filed Jun 2, 2021 16:33 UTC	CMC Materials, Inc. CCMP · Entity 125533	GrantCommon Stock	520	$0.00	$0.00	Disclosure SEC source: 0001127602-21-018708 · form4.xml · nonDerivative · entry 1 Roby Anne K · CIK 0001595290 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 530 F1 · shares: Directors' Initial Restricted Stock Unit Award pursuant to 2021 Omnibus Incentive Plan ("2021 OIP"); vesting schedule: 25% 6/1/2022; 25% 6/1/2023; 25% 6/1/2024; 25% 6/1/2025. Read SEC document
June 03, 2020 Filed Jun 4, 2020 18:34 UTC	LINDE PLC LIN · Entity 2835	Exercise / conversionStock Option (right to buy) · Derivative	9,405	$0.00 Strike: $102.22	$0.00	Disclosure SEC source: 0001707925-20-000052 · edgar.xml · derivative · entry 15 Roby Anne K · CIK 0001595290 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Ordinary Shares · 49,405 shares Expires 2026-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: This option vests over three years in three consecutive equal annual installments beginning on February 23, 2017. Read SEC document
June 03, 2020 Filed Jun 4, 2020 18:34 UTC	LINDE PLC LIN · Entity 2835	Exercise / conversionStock Option (right to buy) · Derivative	15,790	$0.00 Strike: $110.58	$0.00	Disclosure SEC source: 0001707925-20-000052 · edgar.xml · derivative · entry 12 Roby Anne K · CIK 0001595290 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 15,790 shares Expires 2023-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant. Read SEC document
June 03, 2020 Filed Jun 4, 2020 18:34 UTC	LINDE PLC LIN · Entity 2835	SaleOrdinary Shares	6,671	$211.97	$1,414,051.87	Disclosure SEC source: 0001707925-20-000052 · edgar.xml · nonDerivative · entry 5 Roby Anne K · CIK 0001595290 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,292.522 F2 · price: The price reported is the weighted average sale price. The sale prices ranged from $211.73 to $212.14. Upon request of the SEC Staff, Linde plc or a security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price. Read SEC document
June 03, 2020 Filed Jun 4, 2020 18:34 UTC	LINDE PLC LIN · Entity 2835	Tax withholdingOrdinary Shares	11,732	$212.25	$2,490,117.00	Disclosure SEC source: 0001707925-20-000052 · edgar.xml · nonDerivative · entry 4 Roby Anne K · CIK 0001595290 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,963.522 F1 · shares: Shares withheld from option exercise to pay exercise price and taxes. No market sale of shares occurred. Read SEC document
June 03, 2020 Filed Jun 4, 2020 18:34 UTC	LINDE PLC LIN · Entity 2835	Exercise / conversionOrdinary Shares	15,790	$110.58	$1,746,058.20	Disclosure SEC source: 0001707925-20-000052 · edgar.xml · nonDerivative · entry 3 Roby Anne K · CIK 0001595290 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,695.522 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
June 03, 2020 Filed Jun 4, 2020 18:34 UTC	LINDE PLC LIN · Entity 2835	Tax withholdingOrdinary Shares	6,792	$212.02	$1,440,039.84	Disclosure SEC source: 0001707925-20-000052 · edgar.xml · nonDerivative · entry 2 Roby Anne K · CIK 0001595290 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,905.522 F1 · shares: Shares withheld from option exercise to pay exercise price and taxes. No market sale of shares occurred. Read SEC document
June 03, 2020 Filed Jun 4, 2020 18:34 UTC	LINDE PLC LIN · Entity 2835	Exercise / conversionOrdinary Shares	9,405	$102.22	$961,379.10	Disclosure SEC source: 0001707925-20-000052 · edgar.xml · nonDerivative · entry 1 Roby Anne K · CIK 0001595290 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,697.522 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
March 09, 2020 Filed Mar 10, 2020 20:40 UTC	LINDE PLC LIN · Entity 2835	GrantStock Option (right to buy) · Derivative	23,545	$0.00 Strike: $173.13	$0.00	Disclosure SEC source: 0001707925-20-000038 · edgar.xml · derivative · entry 6 Roby Anne K · CIK 0001595290 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,545 Underlying: Ordinary Shares · 23,545 shares Expires 2030-03-09 F4 · derivative.exercise_date: This option vests over three years in three consecutive equal annual installments beginning on March 9, 2021. Read SEC document
March 09, 2020 Filed Mar 10, 2020 20:40 UTC	LINDE PLC LIN · Entity 2835	GrantRestricted Stock Units · Derivative	1,935	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001707925-20-000038 · edgar.xml · derivative · entry 3 Roby Anne K · CIK 0001595290 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,935 Underlying: Ordinary Shares · 1,935 shares Expires not disclosed F1 · derivative.exercise_price: Restricted Stock Units that will vest in full and payout on or about March 9, 2023 in Linde plc Ordinary Shares on a one-for-one basis. F1 · derivative.exercise_date: Restricted Stock Units that will vest in full and payout on or about March 9, 2023 in Linde plc Ordinary Shares on a one-for-one basis. F1 · derivative.expiration_date: Restricted Stock Units that will vest in full and payout on or about March 9, 2023 in Linde plc Ordinary Shares on a one-for-one basis. Read SEC document
March 06, 2020 Filed Mar 10, 2020 20:40 UTC	LINDE PLC LIN · Entity 2835	GrantDeferred Stock Unit · Derivative	63.739	$0.00	$0.00	Disclosure SEC source: 0001707925-20-000038 · edgar.xml · derivative · entry 14 Roby Anne K · CIK 0001595290 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120.569 Underlying: Ordinary Shares · 63.739 shares Expires not disclosed F9 · derivative.exercise_price: Conversion to Linde plc ordinary shares is on a one-for-one basis. F10 · derivative.exercise_date: Deferred stock units acquired under the Compensation Deferred Plan as amended ("Plan"). The deferred stock units will payout in Linde plc Ordinary Shares on a one-for one basis in accordance with the Plan. F10 · derivative.expiration_date: Deferred stock units acquired under the Compensation Deferred Plan as amended ("Plan"). The deferred stock units will payout in Linde plc Ordinary Shares on a one-for one basis in accordance with the Plan. Read SEC document
March 02, 2020 Filed Mar 3, 2020 17:17 UTC	LINDE PLC LIN · Entity 2835	Exercise / conversionRestricted Stock Units · Derivative	2,960	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001707925-20-000029 · edgar.xml · derivative · entry 7 Roby Anne K · CIK 0001595290 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 2,960 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Ordinary shares acquired pursuant to the payout of a restricted stock unit ("RSU") grant made on February 26, 2019. F1 · derivative.exercise_date: Ordinary shares acquired pursuant to the payout of a restricted stock unit ("RSU") grant made on February 26, 2019. F1 · derivative.expiration_date: Ordinary shares acquired pursuant to the payout of a restricted stock unit ("RSU") grant made on February 26, 2019. Read SEC document
March 02, 2020 Filed Mar 3, 2020 17:17 UTC	LINDE PLC LIN · Entity 2835	Exercise / conversionRestricted Stock Units · Derivative	4,328	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001707925-20-000029 · edgar.xml · derivative · entry 6 Roby Anne K · CIK 0001595290 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 4,328 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Ordinary shares acquired pursuant to the payout of a restricted stock unit ("RSU") grant made on February 26, 2019. F1 · derivative.exercise_date: Ordinary shares acquired pursuant to the payout of a restricted stock unit ("RSU") grant made on February 26, 2019. F1 · derivative.expiration_date: Ordinary shares acquired pursuant to the payout of a restricted stock unit ("RSU") grant made on February 26, 2019. Read SEC document
March 02, 2020 Filed Mar 3, 2020 17:17 UTC	LINDE PLC LIN · Entity 2835	Tax withholdingOrdinary Shares	1,372	$191.01	$262,065.72	Disclosure SEC source: 0001707925-20-000029 · edgar.xml · nonDerivative · entry 4 Roby Anne K · CIK 0001595290 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,292.522 F2 · shares: Ordinary shares withheld from RSU payout to cover tax withholdings Read SEC document
March 02, 2020 Filed Mar 3, 2020 17:17 UTC	LINDE PLC LIN · Entity 2835	Exercise / conversionOrdinary Shares	2,960	$0.00	$0.00	Disclosure SEC source: 0001707925-20-000029 · edgar.xml · nonDerivative · entry 3 Roby Anne K · CIK 0001595290 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,664.522 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Ordinary shares acquired pursuant to the payout of a restricted stock unit ("RSU") grant made on February 26, 2019. F1 · price: Ordinary shares acquired pursuant to the payout of a restricted stock unit ("RSU") grant made on February 26, 2019. Read SEC document
March 02, 2020 Filed Mar 3, 2020 17:17 UTC	LINDE PLC LIN · Entity 2835	Tax withholdingOrdinary Shares	1,841	$191.01	$351,649.41	Disclosure SEC source: 0001707925-20-000029 · edgar.xml · nonDerivative · entry 2 Roby Anne K · CIK 0001595290 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,704.522 F2 · shares: Ordinary shares withheld from RSU payout to cover tax withholdings Read SEC document
March 02, 2020 Filed Mar 3, 2020 17:17 UTC	LINDE PLC LIN · Entity 2835	Exercise / conversionOrdinary Shares	4,328	$0.00	$0.00	Disclosure SEC source: 0001707925-20-000029 · edgar.xml · nonDerivative · entry 1 Roby Anne K · CIK 0001595290 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,545.522 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Ordinary shares acquired pursuant to the payout of a restricted stock unit ("RSU") grant made on February 26, 2019. F1 · price: Ordinary shares acquired pursuant to the payout of a restricted stock unit ("RSU") grant made on February 26, 2019. Read SEC document
December 20, 2019 Filed Dec 23, 2019 19:43 UTC	LINDE PLC LIN · Entity 2835	Exercise / conversionStock Option (right to buy) · Derivative	9,215	$0.00 Strike: $109.68	$0.00	Disclosure SEC source: 0001707925-19-000082 · edgar.xml · derivative · entry 10 Roby Anne K · CIK 0001595290 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 9,215 shares Expires 2022-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant. Read SEC document
December 20, 2019 Filed Dec 23, 2019 19:43 UTC	LINDE PLC LIN · Entity 2835	SaleOrdinary Shares	2,402	$212.17	$509,632.34	Disclosure SEC source: 0001707925-19-000082 · edgar.xml · nonDerivative · entry 3 Roby Anne K · CIK 0001595290 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,217.522 Read SEC document
December 20, 2019 Filed Dec 23, 2019 19:43 UTC	LINDE PLC LIN · Entity 2835	Tax withholdingOrdinary Shares	6,813	$213.35	$1,453,553.55	Disclosure SEC source: 0001707925-19-000082 · edgar.xml · nonDerivative · entry 2 Roby Anne K · CIK 0001595290 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,619.522 F1 · shares: Shares withheld from option exercise to pay exercise price and taxes. Read SEC document
December 20, 2019 Filed Dec 23, 2019 19:43 UTC	LINDE PLC LIN · Entity 2835	Exercise / conversionOrdinary Shares	9,215	$109.68	$1,010,701.20	Disclosure SEC source: 0001707925-19-000082 · edgar.xml · nonDerivative · entry 1 Roby Anne K · CIK 0001595290 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,432.522 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
November 19, 2019 Filed Nov 20, 2019 21:12 UTC	LINDE PLC LIN · Entity 2835	Exercise / conversionStock Option (right to buy) · Derivative	9,215	$0.00 Strike: $109.68	$0.00	Disclosure SEC source: 0001707925-19-000079 · edgar.xml · derivative · entry 10 Roby Anne K · CIK 0001595290 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,215 Underlying: Ordinary Shares · 18,430 shares Expires 2022-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant. Read SEC document
November 19, 2019 Filed Nov 20, 2019 21:12 UTC	LINDE PLC LIN · Entity 2835	SaleOrdinary Shares	2,355	$209.51	$493,398.41	Disclosure SEC source: 0001707925-19-000079 · edgar.xml · nonDerivative · entry 3 Roby Anne K · CIK 0001595290 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,217.522 Read SEC document
November 19, 2019 Filed Nov 20, 2019 21:12 UTC	LINDE PLC LIN · Entity 2835	Tax withholdingOrdinary Shares	6,860	$209.49	$1,437,101.40	Disclosure SEC source: 0001707925-19-000079 · edgar.xml · nonDerivative · entry 2 Roby Anne K · CIK 0001595290 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,572.522 F1 · shares: Shares withheld from option exercise to pay exercise price and taxes. Read SEC document
November 19, 2019 Filed Nov 20, 2019 21:12 UTC	LINDE PLC LIN · Entity 2835	Exercise / conversionOrdinary Shares	9,215	$109.68	$1,010,701.20	Disclosure SEC source: 0001707925-19-000079 · edgar.xml · nonDerivative · entry 1 Roby Anne K · CIK 0001595290 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,432.522 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
November 18, 2019 Filed Nov 19, 2019 20:50 UTC	LINDE PLC LIN · Entity 2835	SaleOrdinary Shares	1,583	$209.71	$331,964.44	Disclosure SEC source: 0001707925-19-000078 · edgar.xml · nonDerivative · entry 1 Roby Anne K · CIK 0001595290 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,217.522 Read SEC document
March 20, 2019 Filed Mar 22, 2019 21:32 UTC	LINDE PLC LIN · Entity 2835	Exercise / conversionStock Option (right to buy) · Derivative	13,195	$0.00 Strike: $97.84	$0.00	Disclosure SEC source: 0001707925-19-000024 · edgar.xml · derivative · entry 10 Roby Anne K · CIK 0001595290 · Head of Global Functions Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 13,195 shares Expires 2021-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
March 20, 2019 Filed Mar 22, 2019 21:32 UTC	LINDE PLC LIN · Entity 2835	GrantStock Option (right to buy) · Derivative	26,230	$0.00 Strike: $176.63	$0.00	Disclosure SEC source: 0001707925-19-000024 · edgar.xml · derivative · entry 9 Roby Anne K · CIK 0001595290 · Head of Global Functions Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,230 Underlying: Ordinary Shares · 26,230 shares Expires 2029-03-20 F6 · derivative.exercise_date: This option vests over three years in three consecutive equal annual installments beginning on March 20, 2020. Read SEC document
March 20, 2019 Filed Mar 22, 2019 21:32 UTC	LINDE PLC LIN · Entity 2835	GrantRistricted Stock Units · Derivative	2,330	$0.00	$0.00	Disclosure SEC source: 0001707925-19-000024 · edgar.xml · derivative · entry 5 Roby Anne K · CIK 0001595290 · Head of Global Functions Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,330 Underlying: Ordinary Shares · 2,330 shares Expires not disclosed F3 · derivative.exercise_price: Restricted Stock Units that will vest in full and payout on or about March 20, 2022 in Linde plc Ordinary Shares on a one-for-one-basis. F3 · derivative.exercise_date: Restricted Stock Units that will vest in full and payout on or about March 20, 2022 in Linde plc Ordinary Shares on a one-for-one-basis. F3 · derivative.expiration_date: Restricted Stock Units that will vest in full and payout on or about March 20, 2022 in Linde plc Ordinary Shares on a one-for-one-basis. Read SEC document
March 20, 2019 Filed Mar 22, 2019 21:32 UTC	LINDE PLC LIN · Entity 2835	SaleOrdinary Shares	3,159	$176.77	$558,416.43	Disclosure SEC source: 0001707925-19-000024 · edgar.xml · nonDerivative · entry 3 Roby Anne K · CIK 0001595290 · Head of Global Functions Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,800.522 F2 · price: $176.77 was the average per share sale price. Actual per share prices ranged from $176.77 to $176.79 and will be provided upon the request of the SEC and any shareholder. Read SEC document
March 20, 2019 Filed Mar 22, 2019 21:32 UTC	LINDE PLC LIN · Entity 2835	Tax withholdingOrdinary Shares	10,036	$176.77	$1,774,063.72	Disclosure SEC source: 0001707925-19-000024 · edgar.xml · nonDerivative · entry 2 Roby Anne K · CIK 0001595290 · Head of Global Functions Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,959.502 F1 · shares: Shares withheld for taxes and to pay the option exercise price. Read SEC document
March 20, 2019 Filed Mar 22, 2019 21:32 UTC	LINDE PLC LIN · Entity 2835	Exercise / conversionOrdinary Shares	13,195	$97.84	$1,290,998.80	Disclosure SEC source: 0001707925-19-000024 · edgar.xml · nonDerivative · entry 1 Roby Anne K · CIK 0001595290 · Head of Global Functions Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,995.522 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
February 25, 2019 Filed Feb 27, 2019 23:19 UTC	LINDE PLC LIN · Entity 2835	GrantDeferred Stock Unit · Derivative	56.83	$0.00	$0.00	Disclosure SEC source: 0001707925-19-000005 · edgar.xml · derivative · entry 19 Roby Anne K · CIK 0001595290 · Head of Global Functions Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56.83 Underlying: Ordinary Shares · 56.83 shares Expires not disclosed F8 · derivative.exercise_price: Conversion to Linde plc ordinary shares is on a one-for-one basis. F9 · derivative.exercise_date: Deferred stock units acquired under the Praxair Compensation Deferred Plan as amended ("Deferral Plan") and are to be settled in Linde plc Ordinary Shares. F9 · derivative.expiration_date: Deferred stock units acquired under the Praxair Compensation Deferred Plan as amended ("Deferral Plan") and are to be settled in Linde plc Ordinary Shares. Read SEC document
February 25, 2019 Filed Feb 27, 2019 23:19 UTC	LINDE PLC LIN · Entity 2835	Exercise / conversionRistricted Stock Unit · Derivative	3,588	$0.00	$0.00	Disclosure SEC source: 0001707925-19-000005 · edgar.xml · derivative · entry 7 Roby Anne K · CIK 0001595290 · Head of Global Functions Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 3,588 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Ordinary shares acquired pursuant to the payout of a restricted stock unit ("RSU") grant made on February 23, 2016. F1 · derivative.exercise_date: Ordinary shares acquired pursuant to the payout of a restricted stock unit ("RSU") grant made on February 23, 2016. F1 · derivative.expiration_date: Ordinary shares acquired pursuant to the payout of a restricted stock unit ("RSU") grant made on February 23, 2016. Read SEC document
February 25, 2019 Filed Feb 27, 2019 23:19 UTC	LINDE PLC LIN · Entity 2835	Exercise / conversionRistricted Stock Unit · Derivative	3,510	$0.00	$0.00	Disclosure SEC source: 0001707925-19-000005 · edgar.xml · derivative · entry 6 Roby Anne K · CIK 0001595290 · Head of Global Functions Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 3,510 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Ordinary shares acquired pursuant to the payout of a restricted stock unit ("RSU") grant made on February 23, 2016. F1 · derivative.exercise_date: Ordinary shares acquired pursuant to the payout of a restricted stock unit ("RSU") grant made on February 23, 2016. F1 · derivative.expiration_date: Ordinary shares acquired pursuant to the payout of a restricted stock unit ("RSU") grant made on February 23, 2016. Read SEC document
February 25, 2019 Filed Feb 27, 2019 23:19 UTC	LINDE PLC LIN · Entity 2835	Tax withholdingOrdinary Shares	1,663	$173.50	$288,530.50	Disclosure SEC source: 0001707925-19-000005 · edgar.xml · nonDerivative · entry 5 Roby Anne K · CIK 0001595290 · Head of Global Functions Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,800.522 F2 · shares: Ordinary shares withheld from the RSU payout to cover tax withholdings. Read SEC document
February 25, 2019 Filed Feb 27, 2019 23:19 UTC	LINDE PLC LIN · Entity 2835	Exercise / conversionOrdinary Shares	3,588	$0.00	$0.00	Disclosure SEC source: 0001707925-19-000005 · edgar.xml · nonDerivative · entry 4 Roby Anne K · CIK 0001595290 · Head of Global Functions Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,463.522 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Ordinary shares acquired pursuant to the payout of a restricted stock unit ("RSU") grant made on February 23, 2016. F1 · price: Ordinary shares acquired pursuant to the payout of a restricted stock unit ("RSU") grant made on February 23, 2016. Read SEC document
February 25, 2019 Filed Feb 27, 2019 23:19 UTC	LINDE PLC LIN · Entity 2835	Tax withholdingOrdinary Shares	1,627	$173.50	$282,284.50	Disclosure SEC source: 0001707925-19-000005 · edgar.xml · nonDerivative · entry 3 Roby Anne K · CIK 0001595290 · Head of Global Functions Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,875.522 F2 · shares: Ordinary shares withheld from the RSU payout to cover tax withholdings. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.